Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2023
A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritisYuqing Wang, Duolong Zhu, Laura C Ortiz-Velez, et al.
Frontiers in Pharmacology|October 11, 2021
Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple SclerosisIoannis Markakis, Ioannis Charitakis, Christine Beeton, et al.
The Journal of Biological Chemistry|June 20, 2003
The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sitesAlexei F Kisselev, Margarita Garcia-Calvo, Herman S Overkleeft, et al.
Scientific Reports|June 18, 2017
Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental ratsRalf Bergmann, Manja Kubeil, Kristof Zarschler, et al.
Toxicon : Official Journal of the International Society on Toxinology|May 18, 2018
Synthesis, folding, structure and activity of a predicted peptide from the sea anemone Oulactis sp. with an ShKT foldBankala Krishnarjuna, Jessica Villegas-Moreno, Michela L Mitchell, et al.
Clinical Immunology (Orlando, Fla.)|April 9, 2017
Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analogMark R Tanner, Rajeev B Tajhya, Redwan Huq, et al.
The Journal of Biological Chemistry|November 7, 2007
The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferationChristine Beeton, Brian J Smith, Jennifer K Sabo, et al.
Pageof 6